| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2013-07-09 16:06:17 UTC |
|---|
| Update Date | 2021-09-14 15:25:43 UTC |
|---|
| HMDB ID | HMDB0060903 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Reduced haloperidol |
|---|
| Description | Reduced haloperidol belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. It is in the butyrophenone class of antipsychotic medications and has pharmacological effects similar to the phenothiazines. Reduced haloperidol is a very strong basic compound (based on its pKa). Reduced haloperidol is a metabolite of haloperidol. Haloperidol is an older antipsychotic used in the treatment of schizophrenia and acute psychotic states and delirium. Haloperidol is a typical antipsychotic. |
|---|
| Structure | OC(CCCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)C1=CC=C(F)C=C1 InChI=1S/C21H25ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,20,25-26H,1-2,11-15H2 |
|---|
| Synonyms | | Value | Source |
|---|
| 4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanol | HMDB | | Reduced haloperidol | MeSH | | Hydroxyhaloperidol | MeSH |
|
|---|
| Chemical Formula | C21H25ClFNO2 |
|---|
| Average Molecular Weight | 377.88 |
|---|
| Monoisotopic Molecular Weight | 377.155784961 |
|---|
| IUPAC Name | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol |
|---|
| Traditional Name | 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-hydroxybutyl]piperidin-4-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | OC(CCCN1CCC(O)(CC1)C1=CC=C(Cl)C=C1)C1=CC=C(F)C=C1 |
|---|
| InChI Identifier | InChI=1S/C21H25ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,20,25-26H,1-2,11-15H2 |
|---|
| InChI Key | WNZBBTJFOIOEMP-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Piperidines |
|---|
| Sub Class | Phenylpiperidines |
|---|
| Direct Parent | Phenylpiperidines |
|---|
| Alternative Parents | |
|---|
| Substituents | - Phenylpiperidine
- Phenylbutylamine
- Aralkylamine
- Chlorobenzene
- Fluorobenzene
- Halobenzene
- Aryl chloride
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Benzenoid
- Tertiary alcohol
- Tertiary aliphatic amine
- Tertiary amine
- Secondary alcohol
- Azacycle
- Alcohol
- Organofluoride
- Organochloride
- Organohalogen compound
- Organonitrogen compound
- Organooxygen compound
- Aromatic alcohol
- Hydrocarbon derivative
- Organopnictogen compound
- Organic oxygen compound
- Organic nitrogen compound
- Amine
- Aromatic heteromonocyclic compound
|
|---|
| Molecular Framework | Aromatic heteromonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 6.28 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 10.8709 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 2.84 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1175.1 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 209.7 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 180.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 180.9 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 128.0 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 383.3 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 446.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 623.6 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 814.1 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 313.4 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1194.2 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 245.4 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 326.6 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 549.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 308.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 11.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Reduced haloperidol,1TMS,isomer #1 | C[Si](C)(C)OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 2861.8 | Semi standard non polar | 33892256 | | Reduced haloperidol,1TMS,isomer #2 | C[Si](C)(C)OC1(C2=CC=C(Cl)C=C2)CCN(CCCC(O)C2=CC=C(F)C=C2)CC1 | 2926.7 | Semi standard non polar | 33892256 | | Reduced haloperidol,2TMS,isomer #1 | C[Si](C)(C)OC(CCCN1CCC(O[Si](C)(C)C)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 2846.1 | Semi standard non polar | 33892256 | | Reduced haloperidol,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CCCN1CCC(O)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 3090.8 | Semi standard non polar | 33892256 | | Reduced haloperidol,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)OC1(C2=CC=C(Cl)C=C2)CCN(CCCC(O)C2=CC=C(F)C=C2)CC1 | 3161.2 | Semi standard non polar | 33892256 | | Reduced haloperidol,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)OC(CCCN1CCC(O[Si](C)(C)C(C)(C)C)(C2=CC=C(Cl)C=C2)CC1)C1=CC=C(F)C=C1 | 3321.6 | Semi standard non polar | 33892256 |
|
|---|
| GC-MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (Non-derivatized) - 70eV, Positive | splash10-076r-4955000000-d4605ccb0a63e273e150 | 2017-09-20 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (2 TMS) - 70eV, Positive | splash10-0a5a-9670880000-f526e688452b80393c6f | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted GC-MS | Predicted GC-MS Spectrum - Reduced haloperidol GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS Spectra| Spectrum Type | Description | Splash Key | Deposition Date | Source | View |
|---|
| Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Positive-QTOF | splash10-03fr-0009000000-34094c22bd48e50c75c6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Positive-QTOF | splash10-03fu-0549000000-954ad12bf6275132b8f5 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Positive-QTOF | splash10-0006-4972000000-a14fb311dc8f6dd4fea6 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Negative-QTOF | splash10-004i-0009000000-abde1d76fafd8040c105 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Negative-QTOF | splash10-056r-1239000000-86643aa86096d4ed639f | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Negative-QTOF | splash10-01ot-6930000000-fde008bb1ea71c615c20 | 2017-10-06 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Positive-QTOF | splash10-004i-0009000000-7e459a6c473b027b7520 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Positive-QTOF | splash10-03fr-0019000000-5583edfd6fd7733bf350 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Positive-QTOF | splash10-0002-1901000000-d9271b2da3486c477293 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 10V, Negative-QTOF | splash10-004i-0009000000-46f26e7fc44cc92362d0 | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 20V, Negative-QTOF | splash10-004i-2109000000-1c473b3289a0c30ea73a | 2021-10-12 | Wishart Lab | View Spectrum | | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Reduced haloperidol 40V, Negative-QTOF | splash10-0089-8019000000-9258ff517e784322afba | 2021-10-12 | Wishart Lab | View Spectrum |
|
|---|